Treatment

Letrozole 2.5mg clinical trials

Active studies that list Letrozole 2.5mg as an intervention or treatment.

3active studies

2recruiting now

1countries represented

2largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2, Phase 3

Endometrial Neoplasms, Atypical Endometrial HyperplasiaCondition

GnRHa, Letrozole 2.5mgTreatment

China2 locations

Xiaojun ChenSponsor

Updated 2025-08-11 · NCT05316935See eligibility →

Recruiting nowPhase 2, Phase 3

Endometrial Neoplasms, Atypical Endometrial HyperplasiaCondition

GnRH antagonist, Letrozole 2.5mgTreatment

China2 locations

Xiaojun ChenSponsor

Updated 2025-08-11 · NCT06379113See eligibility →

Active, not recruitingPhase 2, Phase 3

Atypical Endometrial Hyperplasia, Progesterone ResistanceCondition

GnRH antagonist, Letrozole 2.5mgTreatment

China2 locations

Xiaojun ChenSponsor

Updated 2025-08-11 · NCT06390904See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.